Barrientos, Anna Marie .
HRN: 27-86-31 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
AMPICILLIN 1GM (VIAL)
09/26/2025
09/27/2025
IV
2g
Q6hr
Thinly MSAF
Checking Initial Appropriateness
09/26/2025
CEFUROXIME 1.5GM (VIAL)
09/26/2025
09/27/2025
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary LSTCS With IUD
Checking Initial Appropriateness
09/26/2025
CEFUROXIME 500MG (TAB)
09/26/2025
10/03/2025
PO
500mg
BID X 7 Days
S/P Primary LSTCS With IUD
Checking Initial Appropriateness
09/26/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/26/2025
09/27/2025
IV
500mg
Q8hrs X 3 Doses
S/P Primary LSTCS With IUD
Checking Initial Appropriateness
09/26/2025
METRONIDAZOLE 500MG (TAB)
09/26/2025
10/03/2025
PO
500mg
TID X 7 Days
S/P Primary LSTCS With IUD
Checking Initial Appropriateness